{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:27:10Z","timestamp":1786512430083,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07451-6","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:29:39Z","timestamp":1786508979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myopic macular neovascularization as an inducing factor of atrophy in high myopia"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4497-5542","authenticated-orcid":false,"given":"Margarita","family":"Zamorano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M\u00aa","family":"Ruiz-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"V\u00e1zquez-Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariluz","family":"Puertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Flores-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ruiz-Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"1","key":"7451_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","volume":"157","author":"TY Wong","year":"2014","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157(1):9\u201325e12. https:\/\/doi.org\/10.1016\/j.ajo.2013.08.010","journal-title":"Am J Ophthalmol"},{"key":"7451_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2023.02.017","volume":"252","author":"JM Ruiz-Moreno","year":"2023","unstructured":"Ruiz-Moreno JM, Puertas M, Flores-Moreno I, Almaz\u00e1n-Alonso E, Garc\u00eda-Zamora M, Ruiz-Medrano J (2023) Posterior staphyloma as determining factor for myopic maculopathy. Am J Ophthalmol 252:9\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2023.02.017","journal-title":"Am J Ophthalmol"},{"key":"7451_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajo.2024.09.035","volume":"270","author":"I Flores-Moreno","year":"2025","unstructured":"Flores-Moreno I, Puertas M, Fern\u00e1ndez-Jim\u00e9nez M et al (2025) Myopic Maculopathy Progression: Insights Into Posterior Staphyloma and Macular Involvement. Am J Ophthalmol 270:164\u2013171. https:\/\/doi.org\/10.1016\/j.ajo.2024.09.035","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"7451_CR4","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K et al (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110(7):1297\u20131305. https:\/\/doi.org\/10.1016\/S0161-6420(03)00461-5","journal-title":"Ophthalmology"},{"issue":"7","key":"7451_CR5","doi-asserted-by":"publisher","first-page":"e067921","DOI":"10.1136\/bmjopen-2022-067921","volume":"13","author":"L Dong","year":"2023","unstructured":"Dong L, Li G, Song Z, Cheng X, Bai J, Zhang C (2023) Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: A systematic review and meta-analysis of randomised controlled trials. BMJ Open 13(7):e067921. https:\/\/doi.org\/10.1136\/bmjopen-2022-067921","journal-title":"BMJ Open"},{"issue":"8","key":"7451_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","volume":"117","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Ohno-Matsui K, Shimada N et al (2010) Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology 117(8):1595\u20131611 611.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2009.11.003. 4","journal-title":"Ophthalmology"},{"issue":"9","key":"7451_CR7","doi-asserted-by":"publisher","first-page":"e0273613","DOI":"10.1371\/journal.pone.0273613","volume":"17","author":"KW Bae","year":"2022","unstructured":"Bae KW, Kim DI, Kim BH, Oh BL, Lee EK, Yoon CK, Park UC (2022) Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment. PLoS ONE 17(9):e0273613. https:\/\/doi.org\/10.1371\/journal.pone.0273613","journal-title":"PLoS ONE"},{"issue":"5","key":"7451_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","volume":"159","author":"K Ohno-Matsui","year":"2015","unstructured":"Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, Yamazaki M, Meuer S, Ishibashi T, Yasuda M, Yamashita H, Sugano A, Wang JJ, Mitchell P, Wong TY, META-analysis for Pathologic Myopia (META-PM) Study Group (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol.;159(5):877\u2009\u2013\u200983.e7. https:\/\/doi.org\/10.1016\/j.ajo.2015.01.022. Epub 2015 Jan 26. PMID: 25634530.One. 2022;17(9):e0273613. 2022 Sep 22. doi:10.1371\/journal.pone.0273613","journal-title":"Am J Ophthalmol"},{"key":"7451_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.preteyeres.2018.10.005","volume":"69","author":"J Ruiz-Medrano","year":"2019","unstructured":"Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, Garc\u00eda-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80\u2013115. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.005","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"7451_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.oret.2020.12.002","volume":"5","author":"LL Shen","year":"2021","unstructured":"Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Del Priore LV (2021) Geographic Atrophy Growth Is Strongly Related to Lesion Perimeter: Unifying Effects of Lesion Area, Number, and Circularity on Growth. Ophthalmol Retina 5(9):868\u2013878. https:\/\/doi.org\/10.1016\/j.oret.2020.12.002","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"7451_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.survophthal.2023.07.006","volume":"68","author":"XJ Zhang","year":"2023","unstructured":"Zhang XJ, Chen XN, Tang FY et al (2023) Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis. Surv Ophthalmol 68(6):1011\u20131026. https:\/\/doi.org\/10.1016\/j.survophthal.2023.07.006","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"7451_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2017.12.005","volume":"125","author":"Y Fang","year":"2018","unstructured":"Fang Y, Yokoi T, Nagaoka N et al (2018) Progression of Myopic Maculopathy during 18-Year Follow-up. Ophthalmology 125(6):863\u2013877. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.005","journal-title":"Ophthalmology"},{"key":"7451_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajo.2015.11.014","volume":"162","author":"K Ohno-Matsui","year":"2016","unstructured":"Ohno-Matsui K, Jonas JB, Spaide RF (2016) Macular Bruch Membrane Holes in Choroidal Neovascularization-Related Myopic Macular Atrophy by Swept-Source Optical Coherence Tomography. Am J Ophthalmol 162:133\u2013139e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.11.014","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"7451_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.oret.2025.02.015","volume":"9","author":"MM Carl\u00e0","year":"2025","unstructured":"Carl\u00e0 MM, Boselli F, Giannuzzi F et al (2025) Longitudinal progression of myopic maculopathy in a long-term folloW-UP OF a European Cohort: Imaging features and visual outcomes. Ophthalmol Retina 9(8):774\u2013786. https:\/\/doi.org\/10.1016\/j.oret.2025.02.015","journal-title":"Ophthalmol Retina"},{"key":"7451_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/OPTH.S461515","volume":"18","author":"AM Ferreira","year":"2024","unstructured":"Ferreira AM, Vilares-Morgado R, Lima-Fontes M, Falc\u00e3o M, Falc\u00e3o-Reis F, Carneiro \u00c2 (2024) Chorioretinal Atrophic Lesions Evolution in Patients with Quiescent Myopic Choroidal Neovascularization Followed for More Than 10 Years. Clin Ophthalmol 18:1381\u20131390 Published 2024 May 16. https:\/\/doi.org\/10.2147\/OPTH.S461515","journal-title":"Clin Ophthalmol"},{"issue":"14","key":"7451_CR16","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1167\/iovs.17-22633","volume":"58","author":"M Parravano","year":"2017","unstructured":"Parravano M, Scarinci F, Gilardi M et al (2017) Patchy chorioretinal atrophy changes at the posterior pole after ranibizumab for myopic choroidal neovascularization. Invest Ophthalmol Vis Sci 58(14):6358\u20136364. https:\/\/doi.org\/10.1167\/iovs.17-22633","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"7451_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/IAE.0b013e3182278bae","volume":"32","author":"K Hayashi","year":"2012","unstructured":"Hayashi K, Shimada N, Moriyama M, Hayashi W, Tokoro T, Ohno-Matsui K (2012) Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization in Japanese patients with pathologic myopia. Retina 32(4):687\u2013695. https:\/\/doi.org\/10.1097\/IAE.0b013e3182278bae","journal-title":"Retina"},{"issue":"7","key":"7451_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K et al (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110(7):1297\u20131305. https:\/\/doi.org\/10.1016\/S0161-6420(03)00461-5","journal-title":"Ophthalmology"},{"key":"7451_CR19","doi-asserted-by":"publisher","unstructured":"Moukadem O, Motloch K, Couanon M, Gaucher D, Philippakis E, Couturier A (2025) Incidence and enlargement rate of myopic macular neovascularization-related atrophy in highly myopic eyes. Retina Published online November 10. https:\/\/doi.org\/10.1097\/IAE.0000000000004731","DOI":"10.1097\/IAE.0000000000004731"},{"issue":"8","key":"7451_CR20","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/iae.0000000000001384","volume":"37","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee SC, Kim SH, Koh HJ, Kim SS, Byeon SH, Lee CS Choroidal thickness and chorioretinal atrophy in myopic choroidal neovascularization with anti-vascular endothelial growth factor therapy. Retina. 2017 Aug;37(8):1516\u20131522. https:\/\/doi.org\/10.1097\/iae.0000000000001384. pmid: 27798519","journal-title":"Retina"},{"key":"7451_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.12.001","volume":"52","author":"K Ohno-Matsui","year":"2016","unstructured":"Ohno-Matsui K, Lai TY, Lai CC, Cheung CM (2016) Updates of pathologic myopia. Prog Retin Eye Res 52:156\u2013187. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.12.001","journal-title":"Prog Retin Eye Res"},{"key":"7451_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.preteyeres.2012.04.001","volume":"31","author":"K Neelam","year":"2012","unstructured":"Neelam K, Cheung CMG, Ohno-Matsui K et al (2012) Choroidal neovascularization in pathological myopia. Prog Retin Eye Res 31:495\u2013525. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.04.001","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"7451_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/IAE.0000000000003930","volume":"44","author":"Y Kawashima","year":"2024","unstructured":"Kawashima Y, Hata M, Miyake M et al (2024) Macular chorioretinal atrophy and visual outcomes in ranibizumab- or aflibercept-treated myopic choroidal neovascularization. Retina 44(1):127\u2013135. https:\/\/doi.org\/10.1097\/IAE.0000000000003930","journal-title":"Retina"},{"issue":"4","key":"7451_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000357290","volume":"231","author":"CL Farinha","year":"2014","unstructured":"Farinha CL, Baltar AS, Nunes SG et al (2014) Progression of myopic maculopathy after treatment of choroidal neovascularization. Ophthalmologica 231(4):211\u2013220. https:\/\/doi.org\/10.1159\/000357290","journal-title":"Ophthalmologica"},{"issue":"6","key":"7451_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/IAE.0000000000001313","volume":"37","author":"K Kasahara","year":"2017","unstructured":"Kasahara K, Moriyama M, Morohoshi K et al (2017) Six-year outcomes of intravitreal bevacizumab for choroidal neovascularization in patients with pathologic myopia. Retina 37(6):1055\u20131064. https:\/\/doi.org\/10.1097\/IAE.0000000000001313","journal-title":"Retina"},{"issue":"1","key":"7451_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-012-2022-8","volume":"251","author":"A Oishi","year":"2013","unstructured":"Oishi A, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Nakata I, Miyake M, Yoshimura N (2013) Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 251(1):1\u20137. https:\/\/doi.org\/10.1007\/s00417-012-2022-8 Epub 2012 Apr 19. PMID: 22527326","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"7451_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00417-011-1921-4","volume":"250","author":"R Uemoto","year":"2012","unstructured":"Uemoto R, Nakasato-Sonn H, Kawagoe T, Akira M, Okada E, Mizuki N (2012) Factors associated with enlargement of chorioretinal atrophy after intravitreal bevacizumab for myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 250(7):989\u2013997. https:\/\/doi.org\/10.1007\/s00417-011-1921-4 Epub 2012 Jan 22. PMID: 22270217","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"7451_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","volume":"121","author":"FG Holz","year":"2014","unstructured":"Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M (2014) Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology 121(5):1079\u20131091. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.023. Epub 2014 Jan 14. PMID: 24433969","journal-title":"Ophthalmology"},{"key":"7451_CR29","doi-asserted-by":"crossref","unstructured":"Domalpally A, Danis R, Agr\u00f3n E, Blodi B, Clemons T, Chew E, Age-Related Eye Disease Study 2 Research Group (2016) Ophthalmology 123(11):2401\u20132407 Epub 2016 Jul 19. PMID: 27448832; PMCID: PMC5077673. Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11","DOI":"10.1016\/j.ophtha.2016.06.025"},{"issue":"9","key":"7451_CR30","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","volume":"32","author":"AA Khanifar","year":"2012","unstructured":"Khanifar AA, Lederer DE, Ghodasra JH, Stinnett SS, Lee JJ, Cousins SW, Bearelly S (2012) Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area. Retina 32(9):1884\u20131891. https:\/\/doi.org\/10.1097\/IAE.0b013e3182509778PMID: 22547167; PMCID: PMC3697023","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07451-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:29:40Z","timestamp":1786508980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07451-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":30,"alternative-id":["7451"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07451-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}